Market Overview

UPDATE: Morgan Stanley Reiterates on Tyco International Ltd. Ahead of Earnings Call

Related TYC
Benzinga's Top Downgrades
Barclays Downgrades Tyco To Equal-weight
Medtronic to Buy Covidien for $42.0 Billion (Fox Business)

In a report published Friday, Morgan Stanley analyst Nigel Coe reiterated an Overweight rating on Tyco International Ltd. (NYSE: TYC), but removed the $47.00 price target.

In the report, Morgan Stanley noted, “TYC reported 45c which compares to 41c MSe/Street and 39-41c guidance. The results includes a $21m insurance recovery related to the 2012 Chinese accounting irregularities claim. Excluding that, headline EPS falls back to 41c - in line. However the company referred to the gain being more than offset by ‘weakness in Australia' and ‘growth investments'. Therefore, it is uncertain how much of the gain was used to accelerate investments, which is important since ROW margins ex. items declined by 40bps ex-items and gain to 9.3%.”

Tyco International Ltd. closed on Friday at $42.21.

Latest Ratings for TYC

DateFirmActionFromTo
Oct 2014BarclaysDowngradesOverweightEqual-weight
Oct 2014BarclaysMaintainsOverweight
Oct 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for TYC
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Nigel CoeAnalyst Color Price Target Analyst Ratings

 

Related Articles (TYC)

Around the Web, We're Loving...

Get Benzinga's Newsletters